By patenting their innovations, our clients increase the value of their intellectual property and enhance their ability to compete in the marketplace. We work with individual scientists and engineers, laboratory and research teams, and R&D and product development groups to determine whether, when and where it is in our clients' business and technical interests to seek patent protection. And we don't just file patent applications. Drawing on our experience with patent litigation, corporate financings and technology transactions, we implement IP strategies that conserve resources, add measurable value and give our clients a cost-effective and commercially practical competitive edge.

In 2014 alone, we filed nearly 2,000 US and foreign patent applications and obtained more than 600 US and foreign patents for our clients, covering innovations that span the technological spectrum, including aerospace, biochemistry, biotechnology, business methods, chemistry, computer science, fuel cells, genetics, high speed data communication, integrated circuits, materials science, medical devices, nanotechnology, pharmaceuticals, semiconductor devices/processes, and software. We also prepare and prosecute patent applications internationally—under the Patent Cooperative Treaty and in working with a network of seasoned patent lawyers around the world. Our experience extends to appeals, interferences and opposition proceedings within the USPTO, the US Court of Appeals for the Federal Circuit and the European Patent Office. 

Contacts

Sort By
Steinberg, Donald R.

Donald R. Steinberg

Chair, Intellectual Property Department

+1 617 526 6453 (t)

don.steinberg@wilmerhale.com

Love Ph.D., Jane M.

Jane M. Love, Ph.D.

Vice Chair, Intellectual Property Department

+1 212 937 7233 (t)

jane.love@wilmerhale.com

Haag, Joseph F.

Joseph F. Haag

Vice Chair, Intellectual Property Department

+1 650 858 6032 (t)

joseph.haag@wilmerhale.com

Experience

In recent matters, we:

  • Filed and obtained patents covering methods of treatment using NitroMed's commercial drug product, BiDil®—which is targeted to the treatment of heart failure in black patients—and worked with the company on the implementation of strategies for product life cycle management
  • Prosecuted a large and complex family of US and foreign patents for Wyeth and its licensee XCyte, concerning an anti-cancer immunotherapy that is currently in Phase III clinical trials
  • Represented Columbia University in the negotiation of several intellectual property licenses, and in patent prosecution relating to diverse fields such as software applications, integrated circuits, life sciences, chemistry and physical sciences

Publications & News

View

July 9, 2015

Patent Law and the Supreme Court: Certiorari Petitions Denied

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all recently denied petitions, organized in reverse chronological order by date of certiorari petition.

July 9, 2015

Patent Law and the Supreme Court: Certiorari Petitions Granted

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all recently granted petitions, organized in reverse chronological order by date of certiorari petition.

July 9, 2015

Patent Law and the Supreme Court: Certiorari Petitions Pending

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all pending petitions, organized in reverse chronological order by date of certiorari petition.

July 6, 2015

Managing IP Recognizes WilmerHale, Attorneys in 2015 IP Stars Handbook

Managing Intellectual Property has released the third annual edition of its IP Stars Handbook—a guide that identifies the leading IP firms and lawyers in the United States—prominently ranking WilmerHale and 18 of its partners.

July 1, 2015

WilmerHale Named a Leading National Firm in the United States by The Legal 500

The Legal 500 United States has released its annual rankings, selecting WilmerHale as one of the preeminent law firms in the country.

May 29, 2015

A Practitioner's Guide to Section 101 Invalidity: Analyzing Abstract Concepts in the Wake of Alice v. CLS Bank

An article by Louis Tompros, published in Bloomberg BNA's Patent, Trademark & Copyright Journal, Vol. 90, No. 2215.

May 19, 2015

WilmerHale Practices, Lawyers Ranked Among Nation’s Best by Chambers USA

Chambers USA: America's Leading Lawyers for Business announced its final rankings for the 2015 edition, with WilmerHale ranking among the nation's best in 46 practice area categories. Chambers also ranked 86 WilmerHale attorneys as leaders in their respective fields.

March 13, 2015

Teva Pharmaceuticals v. Sandoz: New Rules for Claim Construction Review

An article by Keith Slenkovich, Katherine Lin and Michael Van Handel, published in the Boston Patent Law Association’s Spring 2015 Newsletter, Vol. 26, Issue 1.

March 12, 2015

WilmerHale Lawyers, Practices Recognized in 2015 Edition of Chambers Global

Thirty-two WilmerHale lawyers are named among "The World's Leading Lawyers for Business" in the 2015 edition of Chambers Global. In addition to these individual accolades, the firm is recognized in 17 practice areas that span six different regions.

March 5, 2015

The Future European Patent System: Being Prepared

Dramatic changes to the European patent system are planned for next year or the following year. In particular, there will be a new European patent with unitary effect across, ultimately, 25 EU Member States and a new Unified Patent Court with jurisdiction across all Member States of the EU that have signed up to it.

Patent Cert. Petitions

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all recently pending, granted and denied petitions, organized in each listing in reverse chronological order by date of certiorari petition.

Patent Law and the Supreme Court: Certiorari Petitions Pending

Patent Law and the Supreme Court: Certiorari Petitions Granted

Patent Law and the Supreme Court: Certiorari Petitions Denied

For more information on these petitions or other patent appeal matters, contact:

Joseph J. Mueller (+1 617 526 6396, joseph.mueller@wilmerhale.com)
Thomas G. Saunders (+1 202 663 6536, thomas.saunders@wilmerhale.com)
Leslie Pearlson (+1 617 526 6809, leslie.pearlson@wilmerhale.com)